Re: Switch to Abobotulinum Toxin A May be Useful in the Treatment of Neurogenic Detrusor Overactivity when Intradetrusor Injections of Onabotulinum Toxin A Failed Editorial Comment

被引：0
|
作者：
Wein, Alan J.
机构：
来源：
JOURNAL OF UROLOGY | 2019年 / 201卷 / 03期
关键词：
D O I：
10.1097/01.JU.0000553734.37603.c9
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：451 / 452
页数：2
相关论文
共 50 条
  • [41] Failures and long-term discontinuations of intradetrusor botulinum toxin injections for neurogenic detrusor overactivity: A new challenge in neurourology
    Peyronnet, Benoit
    Game, Xavier
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 (03) : 1182 - 1183
  • [42] Results of botulinum toxin: A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity
    Game, X.
    Roumiguie, M.
    Guillotreau, J.
    Doumerc, N.
    Bordier, B.
    Sallusto, F.
    Malavaud, B.
    Rischmann, P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E466 - U18
  • [43] Re: More than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to be Learned Editorial Comment
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2017, 198 (01): : 177 - 178
  • [44] Editorial Comment: Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity
    Averbeck, Marcio Augusto
    INTERNATIONAL BRAZ J UROL, 2021, 47 (02): : 454 - 455
  • [45] Preliminary results of botulinum toxin A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity
    Peyronnet, Benoit
    Roumiguie, Mathieu
    Castel-Lacanal, Evelyne
    Guillotreau, Julien
    Malavaud, Bernard
    Marque, Philippe
    Rischmann, Pascal
    Game, Xavier
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 (02) : 267 - 270
  • [46] Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity - Editorial comment
    Chancellor, MB
    JOURNAL OF UROLOGY, 2004, 171 (02): : 804 - 805
  • [47] Meta-Analysis of Botulinum Toxin A Detrusor Injections in the Treatment of Neurogenic Detrusor Overactivity After Spinal Cord Injury
    Mehta, Swati
    Hill, Denise
    McIntyre, Amanda
    Foley, Norine
    Hsieh, Jane
    Ethans, Karen
    Teasell, Robert W.
    Loh, Eldon
    Welk, Blayne
    Wolfe, Dalton
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2013, 94 (08): : 1473 - 1481
  • [48] Treatment Outcomes and Resource Use of Patients With Neurogenic Detrusor Overactivity Receiving Botulinum Toxin A (BOTOX) Therapy in Germany Editorial Comment
    Penson, David F.
    JOURNAL OF UROLOGY, 2011, 185 (04): : 1383 - 1384
  • [49] Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity
    Reitz, Andre
    Denys, Pierre
    Fermanian, Christophe
    Schurch, Brigitte
    Comperat, Eva
    Chartier-Kastler, Emmanuel
    EUROPEAN UROLOGY, 2007, 52 (06) : 1729 - 1735
  • [50] Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment
    Mouttalib, Sofia
    Khan, Shahid
    Castel-Lacanal, Evelyne
    Guillotreau, Julien
    De Boissezon, Xavier
    Malavaud, Bernard
    Marque, Philippe
    Rischmann, Pascal
    Game, Xavier
    BJU INTERNATIONAL, 2010, 106 (11) : 1677 - 1680
12345